Neonatal REM sleep is regulated by corticotropin releasing factor

Behavioural Brain Research

Volumn 182, Issue 1, 2007, Pages 95-102

  Feng, Pingfu ^a,b,c   Liu, Xuedong ^a   Vurbic, Drina ^b,c   Fan, Hongkun ^a   Wang, Shuchun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Atropine; Corticotropin releasing factor; NBI 27914; Neonatal rat; REM sleep

Indexed keywords

5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; ATROPINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DIMETHYL SULFOXIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ELECTRODE; NEWBORN; NEWBORN PERIOD; NONHUMAN; NONREM SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; REM SLEEP; SLEEP WAKING CYCLE; WAKEFULNESS;

ACETYLCHOLINE; ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANILINE COMPOUNDS; ANIMALS; ANIMALS, NEWBORN; ATROPINE; BRAIN CHEMISTRY; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MUSCARINIC ANTAGONISTS; POLYSOMNOGRAPHY; PREGNANCY; PYRIMIDINES; RADIOIMMUNOASSAY; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SLEEP, REM; TIME FACTORS; WAKEFULNESS;

EID: 34447275176     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.05.009     Document Type: Article

References (49)

1. Vogel G.W., Feng P., and Kinney G.G. Ontogeny of REM sleep in rats: possible implications for endogenous depression. Physiol Behav 68 (2000) 453-461
2. Jouvet-Mounier D., Astic L., and Lacote D. Ontogenesis of the states of sleep in rat, cat, and guinea pig during the first postnatal month. Dev Psychobiol 2 (1970) 216-239
3. Feng P., Ma Y., and Vogel G.W. The critical window of brain development from susceptive to insusceptive. Effects of clomipramine neonatal treatment on sexual behavior. Brain Res Dev Brain Res 129 (2001) 107-110
4. Feng P., Ma Y., and Vogel G.W. Ontogeny of REM rebound in postnatal rats. Sleep 24 (2001) 645-653
5. Jones S.V., Barker J.L., Goodman M.B., and Brann M.R. Inositol trisphosphate mediates cloned muscarinic receptor-activated conductances in transfected mouse fibroblast A9 L cells. J Physiol 421 (1990) 499-519
6. Mitani A., Ito K., Hallanger A.E., Wainer B.H., Kataoka K., and McCarley R.W. Cholinergic projections from the laterodorsal and pedunculopontine tegmental nuclei to the pontine gigantocellular tegmental field in the cat. Brain Res 451 (1988) 397-402
7. Semba K., Reiner P.B., and Fibiger H.C. Single cholinergic mesopontine tegmental neurons project to both the pontine reticular formation and the thalamus in the rat. Neuroscience 38 (1990) 643-654
8. Shiromani P.J., Armstrong D.M., Berkowitz A., Jeste D.V., and Gillin J.C. Distribution of choline acetyltransferase immunoreactive somata in the feline brainstem: implications for REM sleep generation. Sleep 11 (1988) 1-16
9. Capece M.L., Baghdoyan H.A., and Lydic R. New direction for the study of cholinergic REM sleep generation: Specifying pre- and postsynaptic mechanisms. In: Mallick B.N., and Inoues S. (Eds). Rapid eye movement sleep (1999), Narosa Publishing House 123-141
10. Frank M.G., Page J., and Heller H.C. The effects of REM sleep-inhibiting drugs in neonatal rats: evidence for a distinction between neonatal active sleep and REM sleep. Brain Res 778 (1997) 64-72
11. Hrdina P.D., Ghosh P.K., Rastogi R.B., and Singhal R.L. Ontogenic pattern of dopamine, acetylcholine, and acetylcholinesterase in the brains of normal and hypothyroid rats. Can J Physiol Pharmacol 53 (1975) 709-715
12. Ninomiya Y., Koyama Y., and Kayama Y. Postnatal development of choline acetyltransferase activity in the rat laterodorsal tegmental nucleus. Neurosci Lett 308 (2001) 138-140
13. Balduini W., Cimino M., Reno F., Marini P., Princivalle A., and Cattabeni F. Effects of postnatal or adult chronic acetylcholinesterase inhibition on muscarinic receptors, phosphoinositide turnover and m1 mRNA expression. Eur J Pharmacol 248 (1993) 281-288
14. Buwalda B., de Groote L., Van der Zee E.A., Matsuyama T., and Luiten P.G. Immunocytochemical demonstration of developmental distribution of muscarinic acetylcholine receptors in rat parietal cortex. Brain Res Dev Brain Res 84 (1995) 185-191
15. Mechawar N., Watkins K.C., and Descarries L. Ultrastructural features of the acetylcholine innervation in the developing parietal cortex of rat. J Comp Neurol 443 (2002) 250-258
16. van Huizen F., March D., Cynader M.S., and Shaw C. Muscarinic receptor characteristics and regulation in rat cerebral cortex: changes during development, aging and the oestrous cycle. Eur J Neurosci 6 (1994) 237-243
17. Wall S.J., Yasuda R.P., Li M., Ciesla W., and Wolfe B.B. The ontogeny of m1-m5 muscarinic receptor subtypes in rat forebrain. Brain Res Dev Brain Res 66 (1992) 181-185
18. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
19. Laatikainen T.J. Corticotropin-releasing hormone and opioid peptides in reproduction and stress. Ann Med 23 (1991) 489-496
20. Rivier C., and Rivest S. Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol Reprod 45 (1991) 523-532
21. Webster E.L., Grigoriadis D.E., and De Souza E.B. Corticotropin-releasing factor receptors in the brain-pituitary-immune axis. In: McCubbin J.A., Kaufmann P.J., and Nemeroff C.B. (Eds). Neuropeptides, and systemic disease (1991), Academic Press 233-260
22. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res Brain Res Rev 15 (1990) 71-100
23. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43 (1991) 425-473
24. Challis J., Sloboda D., Matthews S., Holloway A., Alfaidy N., Howe D., et al. Fetal hypothalamic-pituitary adrenal (HPA) development and activation as a determinant of the timing of birth, and of postnatal disease. Endocr Res 26 (2000) 489-504
25. Pihoker C., Cain S.T., and Nemeroff C.B. Postnatal development of regional binding of corticotropin-releasing factor and adenylate cyclase activity in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 16 (1992) 581-586
26. Avishai-Eliner S., Yi S.J., and Baram T.Z. Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Brain Res Dev Brain Res 91 (1996) 159-163
27. Dugovic C., Maccari S., Weibel L., Turek F.W., and Van Reeth O. High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci 19 (1999) 8656-8664
28. Hairston I.S., Ruby N.F., Brooke S., Peyron C., Denning D.P., Heller H.C., et al. Sleep deprivation elevates plasma corticosterone levels in neonatal rats. Neurosci Lett 315 (2001) 29-32
29. Meerlo P., Koehl M., van der Borght K., and Turek F.W. Sleep restriction alters the hypothalamic-pituitary-adrenal response to stress. J Neuroendocrinol 14 (2002) 397-402
30. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160 (1999) 1-12
31. Riemann D., and Berger M. The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder. Acta Psychiatr Scand 81 (1990) 24-31
32. Marrosu F., Gessa G.L., Giagheddu M., and Fratta W. Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats. Brain Res 515 (1990) 315-318
33. Gonzalez M.M., and Valatx J.L. Involvement of stress in the sleep rebound mechanism induced by sleep deprivation in the rat: use of alpha-helical CRH (9-41). Behav Pharmacol 9 (1998) 655-662
34. Feng P. The developmental regulation of wake/sleep system. In: Cardinali D.P., and Pandi-Perumal S.R. (Eds). Neuroendocrine correlates of sleep/wakefulness (2006), Springer 3-18
35. Feng P., and Vogel G.W. A new method for continuous, long-term polysomnographic recording of neonatal rats. Sleep 23 (2000) 9-14
36. Feng P., Guan Z., Yang X., and Fang J. Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. Brain Res 991 (2003) 195-205
37. Frank M.G., Morrissette R., and Heller H.C. Effects of sleep deprivation in neonatal rats. Am J Physiol 275 (1998) R148-R157
38. Feng P., and Ma Y. Clomipramine suppresses postnatal REM sleep without increasing wakefulness: implications for the production of depressive behaviors. Sleep 25 (2002) 177-184
39. Roffwarg H.P., Muzio J.N., and Dement W.C. Development of the human sleep-dream cycle. Science 152 (1966) 604-619
40. Chen C. Recent advances in small molecule antagonists of the corticotropin-releasing factor type-1 receptor-focus on pharmacology and pharmacokinetics. Curr Med Chem 13 (2006) 1261-1282
41. Johanson C.E. Permeability and vascularity of the developing brain: cerebellum vs cerebral cortex. Brain Res 190 (1980) 3-16
42. Parandoosh Z., and Johanson C.E. Ontogeny of blood-brain barrier permeability to, and cerebrospinal fluid sink action on [14C]urea. Am J Physiol 243 (1982) R400-R407
43. Yacavone R.F., Dyas M.L., and Johanson C.E. A developmental analysis of differences in the uptake of [123I]isopropyliodoamphetamine versus 99mTc-pertechnetate by the choroid plexus and brain. Neurochem Res 19 (1994) 379-384
44. Homma Y., Skinner R.D., and Garcia-Rill E. Effects of pedunculopontine nucleus (PPN) stimulation on caudal pontine reticular formation (PnC) neurons in vitro. J Neurophysiol 87 (2002) 3033-3047
45. Opp M.R. Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Adv Neuroimmunol 5 (1995) 127-143
46. Chang F.C., and Opp M.R. A corticotropin-releasing hormone antisense oligodeoxynucleotide reduces spontaneous waking in the rat. Regul Pept 117 (2004) 43-52
47. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24 (2004) 11439-11448
48. Yamamoto Y., Ueta Y., Hara Y., Serino R., Nomura M., Shibuya I., et al. Postnatal development of orexin/hypocretin in rats. Brain Res Mol Brain Res 78 (2000) 108-119
49. Mirmiran M., van de Poll N.E., Corner M.A., van Oyen H.G., and Bour H.L. Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat. Brain Res 204 (1981) 129-146